Obstacles to adoptive TIL and TCR cell therapies, especially cancer cell evasion due to downregulation or loss of antigen and MHC expression, shifted adoptive cell therapy efforts to CAR-T cells (94). The gene discussed is HLA-C; the disease is cancer.